Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells

Journal of General Virology

Volumn 89, Issue 6, 2008, Pages 1525-1532

  Kumar, Rajeev ^a   McLain, Denise ^a   Young, Rebecca ^a   Carlson, George A ^a  

^a MCLAUGHLIN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; MESSENGER RNA; PRION PROTEIN; ABC TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAVEOLA; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; KNOCKOUT GENE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RNA INTERFERENCE; SCRAPIE; TRANSGENIC MOUSE; ANIMAL; BRAIN; COMPARATIVE STUDY; IMMUNOBLOTTING; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

MUS; MUS MUSCULUS; SCRAPIE PRION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; CELL LINE, TUMOR; CHOLESTEROL; IMMUNOBLOTTING; MICE; PRPC PROTEINS; PRPSC PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCRAPIE;

EID: 45949083603     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83358-0     Document Type: Article

References (31)

1. Bate, C., Salmona, M., Diomede, L. & Williams, A. (2004). Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J Biol Chem 279, 14983-14990.
2. Bortnick A. E, Rothblat G. H., Stoudt, G., Hoppe, K. L., Royer, L. J., McNeish, I & Francone, O. L (2000). The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 275, 28634-28640.
3. Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H. P., DeArmond, S. J., Frusiner, S. B, Aguet, M. & Weissmann, C. (1992). Normal development and behaviour of micc lacking (lie neuronal cell-surface PrP protein. Nature 356, 577-582.
4. Sc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol Med 1, 19-30.
5. Cabral, A. L., Lee, K. S. & Martins, V. R. (2002). Regulation of the cellular prion protein gene expression depends on chromatin conformation. J Biol Chem 277, 5675-5682.
6. Campana, V., Sarnataro, D. & Zurzolo, C. (2005). The highways and byways of prion protein trafficking. Trends Cell Biol 15, 102-111.
7. Carlson, G. A., Ebeling, C, Yang, S. L., Telling, G., Torchia, M., Groth, D., Westaway, D., DeArmond, S. J. & Prusiner, S. B. (1994). Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci U S A 91, 5690-5694.
8. Caughey, B. & Raymond, G. J. (1991). The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 266, 18217-18223.
9. DeArmond, S. J. & Ironside, J. W. (1999). Neuropathology of prion diseases. In Prion Biology and Diseases, pp. 585-652. Edited by S. B. Prusiner. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
10. 2-terminal signal anchor sequence that transporter the protein's first hydrophilic domaill to the exoplasmic space. J Biol Chem 276, 15137-15145.
11. Fukumoto, H., Deng, A, Irizarry, M. C, Fitzgerald, M. L. & Rebeck G. W. (2002). Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels. J Biol Chem 277, 48508-48513.
12. Gilch, S., Kehler, C. & Schatzi, H. M. (2006). The prion protein requires cholesterol for cell surface localization. Mol Cell Neurosci 31, 346-353.
13. Harris, D. A. (1999). Cellular biology of prion diseases. Clin Microbiol Rev 12, 429-444.
14. Kaneko, K., Vey, M., Scott, M., Pilkuhn, S., Cohen, F. E. & Prusiner, S. B. (1997). COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci U S A 94, 2333-2338.
15. Koldamova, R. P., Lefterov, I. M., Ikonomovic, M. D., Skoko, J., Lefferov, P. I., Isanski, B. A., DeKosky, S. T. & Lazo, J. S. (2003). 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion. J Biol Chem 278, 13244-13256.
16. Kuczius, T. & Groschup, M. H. (1999). Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Mol Med 5, 406-418.
17. Lawn, R. M., Wade, D. P., Garvin, M. R., Wang, X., Schwartz, K., Porter, J. G., Seilhamer, J. J, Vaughan, A. M. & Oram, J. F. (1999). The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104, R25-R31.
18. Le Goff, W., Zheng, P., Brubaker, G. & Smith, J. D. (2006). Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements. Arterioscler Thromb Vasc Biol 26, 527-533.
19. Marella, M., Lehmann, S., Grassi, J. & Chabry, J. (2002). Filipin prevents pathological prion protein accumulation by reducing endocylosis and inducing cellular PrP release. J Biol Chem 277, 25457-25464.
20. Mendez, A. J., Lin, G., Wade, D. P., Lawn, R. M. & Oram, J. F. (2001). Membrane lipid domains distinct from cholesterol/ sphingomyelinrich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem 276, 3158-3166.
21. Mok S. W., Thelen, K. M., Riemer, C., Bamme, T., Gultner, S., Lutjohann, D. & Baler, M. (2006). Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem Biophys Res Commun 348, 697-702.
22. Orso, E., Broccardo, C., Kaminski, W. E., Bottcher, A., Liebisch, G., Drobnik, W., Gotz, A., Chambenoit, O., Diederich, W. & other authors (2000). Transport of lipids from Golgi to plasma membrane is defective in tangier disease patients and AbcI-deficient mice. Nat Genet 24, 192-196.
23. Peretz, D., Williamson, R. A., Kaneko, K, Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R. & other authors (2001). Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743.
24. Prusiner, S. B. (1998). Prions. Proc Natl Acad Sci U S A 95, 13363-13383.
25. Prusiner, S. B., Scott, M., Foster, D., Pan, K M., Groth, D., Mirenda, C., Torchia, M., Yang, S. L., Serban, D. & other authors (1990). Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-686.
26. Riemer, C., Neidhold, S., Burwinkel, M,, Schwarz, A., Schultz, J., Kratzschmar, J,, Monning, U. & Baler, M. (2004). Gene expression profiling of scrapie-infected brain tissue. Biochem Biophys Res Commun 323, 556-564.
27. c association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol Biol Cell 15, 4031-4042.
28. Taraboulos, A., Scott M., Semenov, A., Avrahami, D., Laszlo, L. & Prusiner, S. B. (1995). Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 129, 121-132.
29. Vey, M., Pilkuhn, S., Wille, H., Nixon, R., DeArmond, S. J., Smart, E. J., Anderson, R. G., Taraboulos, A. & Prusiner, S. B. (1996). Subcellular colocalization of the cellular and scrapie prion proteins in caveolaelike membranous domains. Proc Natl Acad Sci U S A 93, 14945-14949.
30. Xiang, W., Windl, O., Wunsch, G., Dugas, M., Kohimann, A., Dierkes, N., Westner, I. M. & Kretzschmar, H. A. (2004). Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J Virol 78, 11051-11060.
31. Xiang, W., Hummel, M., Mitteregger, G., Pace, C., Windl, O., Mansmann, U. & Kretzschmar, H. A. (2007). Transcriptome analysis reveals altered cholesterol metabolism during the neurodegeneration in mouse scrapie model. J Neurochem 102, 834-847.